CRP

Home - Reagents - CRP
reagents-logo

Key Benefits

Limited Interference

From Conjugate and Free Bilirubin, Haemoglobin, Intralipid and Triglycerides

Wide measuring range

The Randox CRP assay has a wide measuring range of 3.57 – 219 mg/dl which will comfortably detect levels outside of the healthy range

Excellent stability

Stable to expiry when stored at 2-8⁰C

Randox CRP (Immunoturbidimetric)

  • Liquid ready-to-use reagents
  • Stable to expiry when stored at 2-8⁰C
  • Measuring range 3.57 – 219 mg/dl
Cat NoSizeAnalyserEasy Read
Easy Fit
 
CP1423100TDisposable Latex Slide Test--
CP2714100TGlass Latex Slide Test--
CP2852200TSiemens Dimension
CP3826R1 6 x 20ml
R2 3 x 9ml (Latex Enhanced)
RX Daytona/Imola
Hitachi 717/911/912/704/902



CP7950R1 7 x 20ml
R2 2 x 12ml
Hitachi 717/911/912/704/902
RX Daytona/Imola


CP9742R1 6 x 66ml
R2 6 x 13ml
Hitachi 917/Mod P
Abbott Architect
Konelab 20i/30i/60i
Beckman Coulter AU Series






Instrument Specific Applications (ISA’s) are available for a wide range of biochemistry analysers.  Contact us to enquire about your specific analyser.

What is CRP assay used for?

C – reactive protein (CRP) is an acute phase protein produced by the liver in response to inflammation, infection and tissue injury. Increased CRP concentrations occur much earlier than with other acute phase reactants- within 4 to 6 hours- and this rapid response to trauma or infection is the distinguishing feature of CRP. In addition, CRP levels return to normal quickly at the end of an acute episode making CRP useful for both the detection of acute episodes as well as in treatment monitoring.

A complete clinical history is required for accurate interpretation of CRP levels. CRP levels within the normal range may be affected by a number of different factors and should always be compared to previous values.

CRP can be used to aid in the detection of:
  • Viral infections
  • Bacterial infections, including those in neonates
  • Infectious diseases
  • Tissue injury
  • Inflammatory conditions
  • Myocardial infarction
  • Monitoring recovery from surgery, particularly renal transplant patients
  • Valtchanova-Matchouganska, A., et al. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction. Life Sci. 2004, 75(8): 901-910
  • Esmaillzadeh, A., et al. Fruit and vegetables intakes, C-reactive protein, and the metabolic syndrome. Am. J. Clin. Nutr. 2006, 84: 1489-1497
  • Dupuy, A.M., et al. Evaluation of the high-sensitivity, full-range Olympus CRP OSR6199 application on the Olympus AU640R. Clin. Chem. Lab. Med. 2007, 45(3): 402-406
  • Dupuy, A.M., et al. Adaptation and evaluation of the Randox full-range CRP assay on the Olympus AU2700R. J. Clin. Lab. Anal. 2007, 21: 34-39
  • Ramírez Velázquez, C., et al. High-affinity C-reactive protein as inflammatory marker. Rev. Alerg. Mex. 2007, 54(1): 7-13
  • Škopková, M., et al. Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity. 2007, 15(10): 2396-2406
  • Fabre, S., et al. Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis. Clin. Exp. Immunol. 2008. 153(2): 188-195
  • Kjelgaard-Hansen, M., et al. Canine serum C-reactive protein detected by means of a near-patient test for human C-reactive protein. J. Small Anim. Pract. 2008, 49(6): 282-286
  • Bargnoux, A.C., et al. Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. Am. J. Transplant. 2009, 9(11): 2571-2579
  • Connolly, G.M., et al. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation. 2009, 87(7): 1040-1044. (CRP)
  • Klenner, S., et al. Evaluation of three automated human immunoturbidimetric assays for the detection of C-reactive protein in dogs. J. Vet. Diagn. Invest. 2010, 22: 544-552
  • Martins, R.A. et al. Glycated haemoglobin and associated risk factors in older adults. Cardiovasc. Diabetol. 2012, 11: 13
  • Hokayem, M., et al. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2013, 36(6): 1454-1461
Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
  • This field is for validation purposes and should be left unchanged.
×
Kit Insert Request - Reagents
×
Kit Insert Request - Reagents
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Reagents
×
Por favor, introduzca sus datos para ver nuestro último seminario
×